PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia (S.Y.T., N.P.).\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7326/ACPJ202110190-111
?:doi
?:hasPublicationType
?:journal
  • Annals of internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 34606317
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.466
?:rankingScore_hIndex
  • 349
?:title
  • Tofacitinib reduced death or respiratory failure at 28 d in patients hospitalized with COVID-19 pneumonia.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all